International Stem Cell Corporation announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 832,000 compared to USD 941,000 a year ago. Net loss was USD 1.086 million compared to USD 648,000 a year ago. Basic loss per share from continuing operations was USD 0.14 compared to USD 0.09 a year ago. For the half year, operating loss was USD 1.288 million compared to USD 2.430 million a year ago. Net loss was USD 1.459 million compared to USD 1.554 million a year ago. Basic loss per share from continuing operations was USD 0.19 compared to USD 0.21 a year ago.